PointState Capital’s Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 ONSIW Stock Holding History

PointState Capital’s Portfolio ONSIW Stock Details ONSIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-100,000	Closed	-$1K	–	160
2018 Q3	$1K	Hold	100,000	–	–	﹤0.01%	138
2018 Q2	$3K	Hold	100,000	–	–	﹤0.01%	157
2018 Q1	$2K	Hold	100,000	–	–	﹤0.01%	152
2017 Q4	$2K	Hold	100,000	–	–	﹤0.01%	151
2017 Q3	$12K	Hold	100,000	–	–	﹤0.01%	151
2017 Q2	$17K	Hold	100,000	–	–	﹤0.01%	133
2017 Q1	$80K	Hold	100,000	–	–	﹤0.01%	132
2016 Q4	$19K	Hold	100,000	–	–	﹤0.01%	116
2016 Q3	$48K	Hold	100,000	–	–	﹤0.01%	154
2016 Q2	$46K	Buy	+100,000	New	+$38.3K	﹤0.01%	107

PointState Capital's ONSIW Position: Q4 2018 in Review

PointState Capital sold out of Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) in Q4 2018, closing a stake of 100,000 shares — an estimated $1K sold.

PointState Capital first reported a position in ONSIW in Q2 2016 and held it in 10 quarters. The position peaked at $80K in Q1 2017. 0 funds tracked by Wall St. Rank hold ONSIW as of Q4 2018.

PointState Capital reported no remaining Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 position as of Q4 2018 after selling out during the quarter.
PointState Capital sold 100,000 Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 shares in Q4 2018, an estimated $1K.
PointState Capital first reported a position in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 in Q2 2016 and held it in 10 quarters.
PointState Capital's Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 position peaked at $80K in Q1 2017.
0 funds tracked by Wall St. Rank held Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 as of Q4 2018.

Based on PointState Capital's 13F filing for Q4 2018, filed 14 Feb 2019.